Cargando…
Surgical Treatment of Juvenile Idiopathic Arthritis in the Era of Novel Drug Therapies
Juvenile idiopathic arthritis is the most common chronic rheumatic disease encountered in children under the age of sixteen and causes significant impairments in daily life. Over the last two decades, the introduction of new drug treatments (including disease-modifying antirheumatic drugs and biolog...
Autores principales: | Klein, Céline, Barbier, Vincent, Glorion, Christophe, Gouron, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219188/ https://www.ncbi.nlm.nih.gov/pubmed/37240508 http://dx.doi.org/10.3390/jcm12103402 |
Ejemplares similares
-
Juvenile Idiopathic Arthritis in the Era of International Cooperation
por: Uziel, Yosef
Publicado: (2017) -
Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis
por: William, Mridula, et al.
Publicado: (2012) -
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
por: Giancane, Gabriella, et al.
Publicado: (2019) -
A Proteinase 3 Contribution to Juvenile Idiopathic Arthritis-Associated Cartilage Damage
por: Patterson, Eric K., et al.
Publicado: (2021) -
Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis
por: Wobma, Holly, et al.
Publicado: (2023)